|
| |
BioPortfolio's Approved Drugs DatabaseRaptivaEfalizumabDownload PDF containing detailed information.
Press Releases About Raptiva:
|
 |
| Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High |
25th November, 2009 |
BioTrends Research Group, Inc. |
EXTON, Pa., Nov. 25 /PRNewswire/ -- BioTrends Research Group, Inc. released Wave 1 of its LaunchTrends(TM): Stelara report, the first in a multi-phase syndicated market research project tracking the
|
| Reportlinker Adds Monoclonal Antibody Therapies 2007: Competitive Landscape and Pipeline Insight |
5th November, 2009 |
Reportlinker |
NEW YORK, Nov. 5 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
Monoclonal Antibody Therapies 2007: Competitive Landscape and Pipeline
|
| Reportlinker Adds Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment |
26th October, 2009 |
Reportlinker |
-- A focus on "engineered" antibodies
Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment reviews the broad drug development effort that is focused on bringing
|
| Raptiva Withdrawal Offers Upside for Enbrel and Humira According to Latest BioTrends Survey of U.S. Dermatologists |
28th May, 2009 |
BioTrends Research Group, Inc. |
EXTON, Pa., May 28 /PRNewswire/ -- BioTrends Research Group today released its syndicated report TreatmentTrends(R): Psoriasis, the fourth annual survey of U.S. Dermatologists (n=150). The report,
|
| PDL BioPharma Announces First Quarter 2009 Financial Results |
7th May, 2009 |
PDL BioPharma, Inc. |
- Revenues From Continuing Operations Increase 25 Percent to $62.6 Million -
- Conference Call Today at 4:30 p.m. Eastern Time -
INCLINE VILLAGE, Nev., May 7 /PRNewswire-FirstCall/ -- PDL BioPharma,
|
Companies working in the area of Raptiva from Bioportfolio's Biocorporate database : | |
| Company Name | |
XOMA is a leading biopharmaceutical company in the field of therapeutic antibody discovery and development. We have a royalty interest in one approved therapeutic antibody, RAPTIVAŽ (efalizumab),...
www.xoma.com/ View full profile
| |
This page has been viewed 32 times
Recent Search Terms used to find this page: European Medicines Agency Recommends Suspension of Marketing Authorization for Raptiva(R) | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Raptiva across BioPortfolio, or for Raptiva Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
